Dr Peter Simpson takes part in debate around the North West “new golden triangle”

On 25th September 2018 our CSO, Dr Peter Simpson, took part in Insider Media’s New Golden Triangle breakfast event at Alderley Park. The event took the form of a panel that debated whether the North West should compete or collaborate with the original golden triangle of Oxford, Cambridge and London.





Partners in the developing Cheshire Science Corridor outlined their vision to create a “new golden triangle” in the North West last year, linking science, technology and innovation within Cheshire, Manchester and Liverpool. The area, they said, has scope to rival London, Oxford and Cambridge.

At Insider’s event, on 25 September at Alderley Park, speakers discussed the viability of a new golden triangle and how it should be promoted to attract further investment. “The northern golden triangle is marketable on an international stage,” said Julian Cobley, managing director of the Skills & Growth Company (Cheshire East).

Among its assets is Alderley Park. The former AstraZeneca site has been a bio hub for the past four years. The site is expanding further with the Glasshouse set to open next year. The 150,000 sq ft building will cater for high-tech businesses.

Read the full article as a PDF >

 







Other News

News
10 September 2026
Inspiring the next generation: Medicines Discovery Catapult scientist contributes to children’s science book 

Dr Emma Jones, a Lead Scientist in in vitro Neurobiology at Medicines Discovery Catapult (MDC), has contributed to a new children’s book celebrating the diversity of careers in science.


News
03 September 2026
Medicines Discovery Catapult invests in UK biotech pioneers developing novel treatments for chronic diseases

Investment and expert support will help accelerate the development of new treatments for a range of autoimmune, inflammatory, and age-related diseases.


News
22 July 2026
UK Intracellular Drug Delivery Centre opens for industry access to accelerate next-generation RNA medicines 

The centre will provide integrated expertise and evidence generation to help innovators accelerate the development of next-generation RNA medicines.





Medicines Discovery Catapult